Avid Bioservices Inc (CDMO)

[Protector]

geocappy, hard not to log on in a quicky for me.

I don't completely share your opinion but I do agree what I wrote may come across like that given my last sentence and the lack of "what's next" information.

IMO first partner will be for exosomes starting H1/2017. Avid rev yes.
On the R&D front we need a statement as to HWO PPHM will continue the bavituximab study in NSCLC.

But I agree with you that they created a possible 3 months vacuum here, over the change of year period. If they want to avoid the RS as they claim then they need to do a MARCH 2017 action :)

And then I noticed :

It is not there money.